Key result
Corticosteroids plus azathioprine successfully treat eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome.
Why the study?
Idiopathic hypereosinophilic syndrome is a rare condition with challenges in diagnosis and management requiring prompt treatment to prevent complications.
Case Report (n=1)
No
Prompt initiation of corticosteroid therapy and subsequent immunosuppression with azathioprine can effectively manage eosinophilic myocarditis in idiopathic hypereosinophilic syndrome.
Answers are grounded in this paper and cite their sources.
Hypereosinophilic syndrome may mimic STEMI with severe left ventricular dysfunction in young adults; leaves open need for prospective studies on targeted therapy.
Idiopathic hypereosinophilic syndrome is a rare condition characterized by persistent severe eosinophilia and organ damage without any apparent cause. A 20-year-old male patient with no significant medical history was admitted to the Emergency Department with retrosternal chest pain, fatigue and asthenia. EKG showed ST elevation I, II, III, aVF, V4-V6 and blood tests showed elevated troponin levels. An echocardiogram was performed revealing severe global left ventricular systolic dysfunction. Further evaluations included cardiac magnetic resonance imaging and endomyocardial biopsy, confirming the diagnosis of eosinophilic myocarditis. The patient was started on systemic corticosteroid therapy, resulting in clinical improvement. The patient was discharged after 12 days of hospitalization, following a recovery of biventricular function and he was told to continue oral corticosteroid therapy at home. Further investigation ruled out other causes of hypereosinophilic syndromes, therefore the diagnosis of idiopathic hypereosinophilic syndrome was assumed. Despite the attempt to reduce corticosteroid therapy, the eosinophil count became elevated again, so the dosage was increased and associated with azathioprine with subsequent favorable analytical evolution. This case highlights the challenges in diagnosing and managing idiopathic hypereosinophilic syndrome and emphasizes the importance of prompt treatment initiation to prevent complications.
No takes yet. Share an insight, caveat, or question.
Agudo et al. (2023) conducted a case report in Idiopathic Hypereosinophilic Syndrome (n=1). Systemic corticosteroid therapy and azathioprine was evaluated on Clinical improvement and eosinophil count reduction. Systemic corticosteroid therapy combined with azathioprine successfully treated eosinophilic myocarditis and controlled eosinophil counts in a patient with idiopathic hypereosinophilic syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: